Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 67 entries
Sorted by: Best Match Show Resources per page
Is there a need for resident training in clinical trial design?.

International journal of radiation oncology, biology, physics

Berman AT, Shea JA, Baffic C, Vapiwala N.
PMID: 24606857
Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):969-70. doi: 10.1016/j.ijrobp.2013.12.023.

No abstract available.

Cite
Berman AT, Shea JA, Baffic C, et al. Is there a need for resident training in clinical trial design?. Int J Radiat Oncol Biol Phys. 2014;88(4):969-70doi: 10.1016/j.ijrobp.2013.12.023.
Berman, A. T., Shea, J. A., Baffic, C., & Vapiwala, N. (2014). Is there a need for resident training in clinical trial design?. International journal of radiation oncology, biology, physics, 88(4), 969-70. https://doi.org/10.1016/j.ijrobp.2013.12.023
Berman, Abigail T, et al. "Is there a need for resident training in clinical trial design?." International journal of radiation oncology, biology, physics vol. 88,4 (2014): 969-70. doi: https://doi.org/10.1016/j.ijrobp.2013.12.023
Berman AT, Shea JA, Baffic C, Vapiwala N. Is there a need for resident training in clinical trial design?. Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):969-70. doi: 10.1016/j.ijrobp.2013.12.023. PMID: 24606857.
Copy Download .nbib Format: NLM
Phase I randomized double-blind placebo-controlled single-dose safety studies of Bowman-Birk inhibitor concentrate.

Oncology letters

Lin LL, Mick R, Ware J, Metz J, Lustig R, Vapiwala N, Rengan R, Kennedy AR.
PMID: 24944684
Oncol Lett. 2014 Apr;7(4):1151-1158. doi: 10.3892/ol.2014.1855. Epub 2014 Feb 05.

In previously performed animal studies and Phase I-II human trials, Bowman-Birk inhibitor concentrate (BBIC) appeared to be a promising cancer chemopreventive agent. The present study describes the results of two phase I randomized double-blind placebo-controlled trials performed in male...

Cite
Lin LL, Mick R, Ware J, et al. Phase I randomized double-blind placebo-controlled single-dose safety studies of Bowman-Birk inhibitor concentrate. Oncol Lett. 2014;7(4):1151-1158doi: 10.3892/ol.2014.1855.
Lin, L. L., Mick, R., Ware, J., Metz, J., Lustig, R., Vapiwala, N., Rengan, R., & Kennedy, A. R. (2014). Phase I randomized double-blind placebo-controlled single-dose safety studies of Bowman-Birk inhibitor concentrate. Oncology letters, 7(4), 1151-1158. https://doi.org/10.3892/ol.2014.1855
Lin, Lilie L, et al. "Phase I randomized double-blind placebo-controlled single-dose safety studies of Bowman-Birk inhibitor concentrate." Oncology letters vol. 7,4 (2014): 1151-1158. doi: https://doi.org/10.3892/ol.2014.1855
Lin LL, Mick R, Ware J, Metz J, Lustig R, Vapiwala N, Rengan R, Kennedy AR. Phase I randomized double-blind placebo-controlled single-dose safety studies of Bowman-Birk inhibitor concentrate. Oncol Lett. 2014 Apr;7(4):1151-1158. doi: 10.3892/ol.2014.1855. Epub 2014 Feb 05. PMID: 24944684; PMCID: PMC3961219.
Copy Download .nbib Format: NLM
Non-identical yet similar: presentation of coronary artery disease in dizygotic twins.

Cardiovascular diagnosis and therapy

Patil SS, Ramalingam R, Subramanyam K, Pujar D, Manjunath CN, Gajiwala N, Thakkar A.
PMID: 25984455
Cardiovasc Diagn Ther. 2015 Apr;5(2):145-9. doi: 10.3978/j.issn.2223-3652.2015.01.11.

There is a considerable debate regarding the role of genetic and the environmental factors in the pathogenesis of coronary artery disease (CAD). Since twin pairs are exposed to similar prenatal and postnatal environmental factors, a particular role of genetic...

Cite
Patil SS, Ramalingam R, Subramanyam K, et al. Non-identical yet similar: presentation of coronary artery disease in dizygotic twins. Cardiovasc Diagn Ther. 2015;5(2):145-9doi: 10.3978/j.issn.2223-3652.2015.01.11.
Patil, S. S., Ramalingam, R., Subramanyam, K., Pujar, D., Manjunath, C. N., Gajiwala, N., & Thakkar, A. (2015). Non-identical yet similar: presentation of coronary artery disease in dizygotic twins. Cardiovascular diagnosis and therapy, 5(2), 145-9. https://doi.org/10.3978/j.issn.2223-3652.2015.01.11
Patil, Shivanand S, et al. "Non-identical yet similar: presentation of coronary artery disease in dizygotic twins." Cardiovascular diagnosis and therapy vol. 5,2 (2015): 145-9. doi: https://doi.org/10.3978/j.issn.2223-3652.2015.01.11
Patil SS, Ramalingam R, Subramanyam K, Pujar D, Manjunath CN, Gajiwala N, Thakkar A. Non-identical yet similar: presentation of coronary artery disease in dizygotic twins. Cardiovasc Diagn Ther. 2015 Apr;5(2):145-9. doi: 10.3978/j.issn.2223-3652.2015.01.11. PMID: 25984455; PMCID: PMC4420676.
Copy Download .nbib Format: NLM
SU-E-J-153: Volumetric and Dosimetric Variations of Post-Prostatectomy Patients Treated with Radiation Therapy and Endorectal Ballon.

Medical physics

Yin L, Vapiwala N, Swisher-McClur S, Bui V, Deville C, Tochner Z, Both S.
PMID: 28518906
Med Phys. 2012 Jun;39(6):3687-3688. doi: 10.1118/1.4734991.

PURPOSE: Post-prostatectomy patients may be treated with endorectal balloon (ERB) placed during the radiation therapy. The objectives of this tudy are to investigate geometrical variation of organs at risk (OAR) and CTVs (based on RTOG and EORTC guidelines) throughout...

Cite
Yin L, Vapiwala N, Swisher-McClur S, et al. SU-E-J-153: Volumetric and Dosimetric Variations of Post-Prostatectomy Patients Treated with Radiation Therapy and Endorectal Ballon. Med Phys. 2012;39(6):3687-3688doi: 10.1118/1.4734991.
Yin, L., Vapiwala, N., Swisher-McClur, S., Bui, V., Deville, C., Tochner, Z., & Both, S. (2012). SU-E-J-153: Volumetric and Dosimetric Variations of Post-Prostatectomy Patients Treated with Radiation Therapy and Endorectal Ballon. Medical physics, 39(6), 3687-3688. https://doi.org/10.1118/1.4734991
Yin, L, et al. "SU-E-J-153: Volumetric and Dosimetric Variations of Post-Prostatectomy Patients Treated with Radiation Therapy and Endorectal Ballon." Medical physics vol. 39,6 (2012): 3687-3688. doi: https://doi.org/10.1118/1.4734991
Yin L, Vapiwala N, Swisher-McClur S, Bui V, Deville C, Tochner Z, Both S. SU-E-J-153: Volumetric and Dosimetric Variations of Post-Prostatectomy Patients Treated with Radiation Therapy and Endorectal Ballon. Med Phys. 2012 Jun;39(6):3687-3688. doi: 10.1118/1.4734991. PMID: 28518906.
Copy Download .nbib Format: NLM
Patient initiation of complementary and alternative medical therapies (CAM) following cancer diagnosis.

Cancer journal (Sudbury, Mass.)

Vapiwala N, Mick R, Hampshire MK, Metz JM, DeNittis AS.
PMID: 17207316
Cancer J. 2006 Nov-Dec;12(6):467-74. doi: 10.1097/00130404-200611000-00006.

PURPOSE: Complementary and alternative medicine use is prevalent in both healthy and oncologic populations. However, few data exist to quantify complementary and alternative medicine initiation specifically after cancer diagnosis. This study evaluated patients' complementary and alternative medicine usage patterns,...

Cite
Vapiwala N, Mick R, Hampshire MK, et al. Patient initiation of complementary and alternative medical therapies (CAM) following cancer diagnosis. Cancer J. 2006;12(6):467-74doi: 10.1097/00130404-200611000-00006.
Vapiwala, N., Mick, R., Hampshire, M. K., Metz, J. M., & DeNittis, A. S. (2006). Patient initiation of complementary and alternative medical therapies (CAM) following cancer diagnosis. Cancer journal (Sudbury, Mass.), 12(6), 467-74. https://doi.org/10.1097/00130404-200611000-00006
Vapiwala, Neha, et al. "Patient initiation of complementary and alternative medical therapies (CAM) following cancer diagnosis." Cancer journal (Sudbury, Mass.) vol. 12,6 (2006): 467-74. doi: https://doi.org/10.1097/00130404-200611000-00006
Vapiwala N, Mick R, Hampshire MK, Metz JM, DeNittis AS. Patient initiation of complementary and alternative medical therapies (CAM) following cancer diagnosis. Cancer J. 2006 Nov-Dec;12(6):467-74. doi: 10.1097/00130404-200611000-00006. PMID: 17207316.
Copy Download .nbib Format: NLM
Ototoxic effects of irradiation.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India

Upadhya I, Jariwala N, Datar J.
PMID: 22468252
Indian J Otolaryngol Head Neck Surg. 2011 Apr;63(2):151-4. doi: 10.1007/s12070-011-0142-9. Epub 2011 Feb 23.

In this study ototoxic effect of ionizing radiation was studied in 70 ears with minimum follow up of 6 months post radiotherapy. Patients of nasopharyngeal carcinoma and with conductive deafness pre radiotherapy were excluded from the study to eliminate...

Cite
Upadhya I, Jariwala N, Datar J. Ototoxic effects of irradiation. Indian J Otolaryngol Head Neck Surg. 2011;63(2):151-4doi: 10.1007/s12070-011-0142-9.
Upadhya, I., Jariwala, N., & Datar, J. (2011). Ototoxic effects of irradiation. Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 63(2), 151-4. https://doi.org/10.1007/s12070-011-0142-9
Upadhya, I, et al. "Ototoxic effects of irradiation." Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India vol. 63,2 (2011): 151-4. doi: https://doi.org/10.1007/s12070-011-0142-9
Upadhya I, Jariwala N, Datar J. Ototoxic effects of irradiation. Indian J Otolaryngol Head Neck Surg. 2011 Apr;63(2):151-4. doi: 10.1007/s12070-011-0142-9. Epub 2011 Feb 23. PMID: 22468252; PMCID: PMC3102171.
Copy Download .nbib Format: NLM
The Perineural Invasion Paradox: Is Perineural Invasion an Independent Prognostic Indicator of Biochemical Recurrence Risk in Patients With pT2N0R0 Prostate Cancer? A Multi-Institutional Study.

Advances in radiation oncology

Kraus RD, Barsky A, Ji L, Garcia Santos PM, Cheng N, Groshen S, Vapiwala N, Ballas LK.
PMID: 30706016
Adv Radiat Oncol. 2018 Sep 19;4(1):96-102. doi: 10.1016/j.adro.2018.09.006. eCollection 2019.

PURPOSE: Perineural invasion (PNI) is a histologic feature that is present in as many as 84% of patients with prostate cancer. The prognostic significance of PNI is controversial, with recent studies yielding contradictory results. This study aims to assess...

Cite
Kraus RD, Barsky A, Ji L, et al. The Perineural Invasion Paradox: Is Perineural Invasion an Independent Prognostic Indicator of Biochemical Recurrence Risk in Patients With pT2N0R0 Prostate Cancer? A Multi-Institutional Study. Adv Radiat Oncol. 2018;4(1):96-102doi: 10.1016/j.adro.2018.09.006.
Kraus, R. D., Barsky, A., Ji, L., Garcia Santos, P. M., Cheng, N., Groshen, S., Vapiwala, N., & Ballas, L. K. (2019). The Perineural Invasion Paradox: Is Perineural Invasion an Independent Prognostic Indicator of Biochemical Recurrence Risk in Patients With pT2N0R0 Prostate Cancer? A Multi-Institutional Study. Advances in radiation oncology, 4(1), 96-102. https://doi.org/10.1016/j.adro.2018.09.006
Kraus, Ryan Douglas, et al. "The Perineural Invasion Paradox: Is Perineural Invasion an Independent Prognostic Indicator of Biochemical Recurrence Risk in Patients With pT2N0R0 Prostate Cancer? A Multi-Institutional Study." Advances in radiation oncology vol. 4,1 (2019): 96-102. doi: https://doi.org/10.1016/j.adro.2018.09.006
Kraus RD, Barsky A, Ji L, Garcia Santos PM, Cheng N, Groshen S, Vapiwala N, Ballas LK. The Perineural Invasion Paradox: Is Perineural Invasion an Independent Prognostic Indicator of Biochemical Recurrence Risk in Patients With pT2N0R0 Prostate Cancer? A Multi-Institutional Study. Adv Radiat Oncol. 2018 Sep 19;4(1):96-102. doi: 10.1016/j.adro.2018.09.006. eCollection 2019. PMID: 30706016; PMCID: PMC6349660.
Copy Download .nbib Format: NLM
A Pragmatic Evaluation of the National Cancer Institute Physician Data Query (PDQ)®-Based Brief Counseling on Cancer-Related Fatigue among Patients Undergoing Radiation Therapy.

Journal of palliative care & medicine

Bauml J, Xie SX, Penn C, Desai K, Dong KW, Bruner DW, Vapiwala N, Mao JJ.
PMID: 29479490
J Palliat Care Med. 2012;2(6). doi: 10.4172/2165-7386.1000125. Epub 2012 Aug 08.

PURPOSE: Cancer-Related Fatigue (CRF) negatively affects quality of life among cancer patients. This study seeks to evaluate the outcome and patient receptiveness of a brief counseling program based on National Cancer Institute (NCI) PDQ® information to manage CRF when...

Cite
Bauml J, Xie SX, Penn C, et al. A Pragmatic Evaluation of the National Cancer Institute Physician Data Query (PDQ)®-Based Brief Counseling on Cancer-Related Fatigue among Patients Undergoing Radiation Therapy. J Palliat Care Med. 2012;2(6)doi: 10.4172/2165-7386.1000125.
Bauml, J., Xie, S. X., Penn, C., Desai, K., Dong, K. W., Bruner, D. W., Vapiwala, N., & Mao, J. J. (2012). A Pragmatic Evaluation of the National Cancer Institute Physician Data Query (PDQ)®-Based Brief Counseling on Cancer-Related Fatigue among Patients Undergoing Radiation Therapy. Journal of palliative care & medicine, 2(6), . https://doi.org/10.4172/2165-7386.1000125
Bauml, Joshua, et al. "A Pragmatic Evaluation of the National Cancer Institute Physician Data Query (PDQ)®-Based Brief Counseling on Cancer-Related Fatigue among Patients Undergoing Radiation Therapy." Journal of palliative care & medicine vol. 2,6 (2012). doi: https://doi.org/10.4172/2165-7386.1000125
Bauml J, Xie SX, Penn C, Desai K, Dong KW, Bruner DW, Vapiwala N, Mao JJ. A Pragmatic Evaluation of the National Cancer Institute Physician Data Query (PDQ)®-Based Brief Counseling on Cancer-Related Fatigue among Patients Undergoing Radiation Therapy. J Palliat Care Med. 2012;2(6). doi: 10.4172/2165-7386.1000125. Epub 2012 Aug 08. PMID: 29479490; PMCID: PMC5824725.
Copy Download .nbib Format: NLM
Resident satisfaction with radiation oncology training.

Advances in radiation oncology

Ahmed AA, Ramey SJ, Dean MK, Yoo SK, Holliday E, Deville C, Takita C, Vapiwala N, Wilson LD, Jagsi R, Thomas CR, Yechieli R.
PMID: 30197935
Adv Radiat Oncol. 2018 Mar 20;3(3):234-239. doi: 10.1016/j.adro.2018.03.003. eCollection 2018.

PURPOSE: Residency training environments can differ significantly; therefore, resident satisfaction may vary widely among programs. Here, we sought to examine several variables in program satisfaction through a survey of radiation oncology (RO) trainees in the United States.METHODS AND MATERIALS:...

Cite
Ahmed AA, Ramey SJ, Dean MK, et al. Resident satisfaction with radiation oncology training. Adv Radiat Oncol. 2018;3(3):234-239doi: 10.1016/j.adro.2018.03.003.
Ahmed, A. A., Ramey, S. J., Dean, M. K., Yoo, S. K., Holliday, E., Deville, C., Takita, C., Vapiwala, N., Wilson, L. D., Jagsi, R., Thomas, C. R., & Yechieli, R. (2018). Resident satisfaction with radiation oncology training. Advances in radiation oncology, 3(3), 234-239. https://doi.org/10.1016/j.adro.2018.03.003
Ahmed, Awad A, et al. "Resident satisfaction with radiation oncology training." Advances in radiation oncology vol. 3,3 (2018): 234-239. doi: https://doi.org/10.1016/j.adro.2018.03.003
Ahmed AA, Ramey SJ, Dean MK, Yoo SK, Holliday E, Deville C, Takita C, Vapiwala N, Wilson LD, Jagsi R, Thomas CR, Yechieli R. Resident satisfaction with radiation oncology training. Adv Radiat Oncol. 2018 Mar 20;3(3):234-239. doi: 10.1016/j.adro.2018.03.003. eCollection 2018. PMID: 30197935; PMCID: PMC6127972.
Copy Download .nbib Format: NLM
The role of AEG-1 in the development of liver cancer.

Hepatic oncology

Robertson CL, Srivastava J, Rajasekaran D, Gredler R, Akiel MA, Jariwala N, Siddiq A, Emdad L, Fisher PB, Sarkar D.
PMID: 26798451
Hepat Oncol. 2015;2(3):303-312. doi: 10.2217/hep.15.10.

AEG-1 is an oncogene that is overexpressed in all cancers, including hepatocellular carcinoma. AEG-1 plays a seminal role in promoting cancer development and progression by augmenting proliferation, invasion, metastasis, angiogenesis and chemoresistance, all hallmarks of aggressive cancer. AEG-1 mediates...

Cite
Robertson CL, Srivastava J, Rajasekaran D, et al. The role of AEG-1 in the development of liver cancer. Hepat Oncol. 2015;2(3):303-312doi: 10.2217/hep.15.10.
Robertson, C. L., Srivastava, J., Rajasekaran, D., Gredler, R., Akiel, M. A., Jariwala, N., Siddiq, A., Emdad, L., Fisher, P. B., & Sarkar, D. (2015). The role of AEG-1 in the development of liver cancer. Hepatic oncology, 2(3), 303-312. https://doi.org/10.2217/hep.15.10
Robertson, Chadia L, et al. "The role of AEG-1 in the development of liver cancer." Hepatic oncology vol. 2,3 (2015): 303-312. doi: https://doi.org/10.2217/hep.15.10
Robertson CL, Srivastava J, Rajasekaran D, Gredler R, Akiel MA, Jariwala N, Siddiq A, Emdad L, Fisher PB, Sarkar D. The role of AEG-1 in the development of liver cancer. Hepat Oncol. 2015;2(3):303-312. doi: 10.2217/hep.15.10. PMID: 26798451; PMCID: PMC4717832.
Copy Download .nbib Format: NLM
Secondary malignancy after radiotherapy: not always a secondary concern.

Nature reviews. Urology

Reddy VK, Vapiwala N.
PMID: 34083799
Nat Rev Urol. 2021 Sep;18(9):513-514. doi: 10.1038/s41585-021-00486-w.

No abstract available.

Cite
Reddy VK, Vapiwala N. Secondary malignancy after radiotherapy: not always a secondary concern. Nat Rev Urol. 2021;18(9):513-514doi: 10.1038/s41585-021-00486-w.
Reddy, V. K., & Vapiwala, N. (2021). Secondary malignancy after radiotherapy: not always a secondary concern. Nature reviews. Urology, 18(9), 513-514. https://doi.org/10.1038/s41585-021-00486-w
Reddy, Vishruth K, and Vapiwala, Neha. "Secondary malignancy after radiotherapy: not always a secondary concern." Nature reviews. Urology vol. 18,9 (2021): 513-514. doi: https://doi.org/10.1038/s41585-021-00486-w
Reddy VK, Vapiwala N. Secondary malignancy after radiotherapy: not always a secondary concern. Nat Rev Urol. 2021 Sep;18(9):513-514. doi: 10.1038/s41585-021-00486-w. PMID: 34083799.
Copy Download .nbib Format: NLM
Clinically Undetectable Heart Sounds in Hospitalized Patients Undergoing Echocardiography.

JAMA internal medicine

Jariwala N, Czako S, Brenton L, Doherty A, Singh K, Klapman S, McBride J.
PMID: 34779823
JAMA Intern Med. 2022 Jan 01;182(1):86-87. doi: 10.1001/jamainternmed.2021.6594.

No abstract available.

Cite
Jariwala N, Czako S, Brenton L, et al. Clinically Undetectable Heart Sounds in Hospitalized Patients Undergoing Echocardiography. JAMA Intern Med. 2022;182(1):86-87doi: 10.1001/jamainternmed.2021.6594.
Jariwala, N., Czako, S., Brenton, L., Doherty, A., Singh, K., Klapman, S., & McBride, J. (2022). Clinically Undetectable Heart Sounds in Hospitalized Patients Undergoing Echocardiography. JAMA internal medicine, 182(1), 86-87. https://doi.org/10.1001/jamainternmed.2021.6594
Jariwala, Nancy, et al. "Clinically Undetectable Heart Sounds in Hospitalized Patients Undergoing Echocardiography." JAMA internal medicine vol. 182,1 (2022): 86-87. doi: https://doi.org/10.1001/jamainternmed.2021.6594
Jariwala N, Czako S, Brenton L, Doherty A, Singh K, Klapman S, McBride J. Clinically Undetectable Heart Sounds in Hospitalized Patients Undergoing Echocardiography. JAMA Intern Med. 2022 Jan 01;182(1):86-87. doi: 10.1001/jamainternmed.2021.6594. PMID: 34779823; PMCID: PMC8593827.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 67 entries